3 hours Revance Therapeutics, Inc. (NASDAQ:RVNC) Receives Consensus Rating of “Hold” from AnalystsMarketBeat
Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) have received a consensus rating of “Hold” from the nine brokerages that are currently covering the stock, MarketBeat Ratings reports. Eight analysts have rated the stock with a hold…
X